drugset / Trial / NCT01808547

Comparison Study of ISV-303 to Durasite Vehicle in Cataract Surgery Subjects

NCT01808547

Phase 3 Completed 268 enrolled Sun Pharmaceutical Industries, Inc.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate the ocular safety, tolerability and efficacy of topical administration of ISV-303 compared with Durasite Vehicle.

Timeline

Start
2013-05
Primary completion
2013-11
Completion
2013-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Bromfenac Other / unclassified 0.075 % Topical

Indications